S&P Biotech SPDR (XBI)
$81.49 1.53 (1.84%)
19:59 EDT XBI Stock Quote Delayed 15 Minutes
Previous Close $81.49
Market Cap 4.40B
PE Ratio -
Volume (Avg. Vol.) 3.08M
Day's Range 81.45 - 83.11
52-Week Range 64.38 - 101.55
Dividend & Yield 0.23 (0.28%)
XBI Stock Predictions, Articles, and S&P Biotech SPDR News
- From InvestorPlace
- From the Web
This morning I am recommending a bearish trade on the iShares Nasdaq Biotechnology ETF (NASDAQ:IBB).
As the Best ETFs contest enters its final quarter, there are a few contenders that could reasonably take the trophy for 2018.
As our Best ETFs for 2018 contest crosses into the second half of the year, a few contestants are really making standout gains, but others are making strong moves.
The biotech sector peaked in 2015. While it bounced back from lows, biotech ETFs give investors exposure to the sector as it recovers.
A phase of weakness has hit Wall Street, but the dip could be a buy. Here are three bullish options trades to consider in V, BIDU and XBI.
Which funds are going to kick the competition to the curb this year? We have 10 experts who think they know the best ETFs for 2018.
XBI can profit from full drug pipelines, an improving regulatory climate, high short interest and strengthening technicals.
By Jeff Reeves
The best healthcare ETFs for 2018 offer growth and stability. These funds show healthcare investing is both low risk and high reward.
Biotech stocks are scary when they are falling. Sell downside risk into BIIB stock support with confidence for a chance at free profits.
For a while GILD stock was a hideous knife to catch. But now that it reestablished its bottom, I can safely make money in Gilead.
Pharma stocks like Allergan scare most investors out of trading them when they fall. Sell AGN puts with a big buffer for easy profits.
Biotech stocks are leading the charge in this bull market. And last week's drop is a golden opportunity for buying these three beauties.
Biotechnology investors have turned the equal-weight SPDR S&P Biotech ETF (XBI) into one of the largest sector plays. Is it right for you?
The biotech trade is always a momentum bet, and currently Wall Street is betting it will go up. I can use this play in XBI for free income.
Investors fear Amgen (AMGN) is a falling knife after dropping on earnings. Use that fear to sell puts for income in AMGN stock.
The SPDR S&P Biotech ETF is forming a bull flag. Here's how to play biotech stocks for profit in XBI.
Biotech stocks, including Celgene, are pulling back. CELG stock is one of the best dip-buying opportunities of the bunch.
10 Stocks Set for Monster Growth
He found Apple at $4… Oracle at $6… Amazon at $40… Now legendary growth investor Louis Navellier is giving away his latest Research Report — for FREE!
Download your FREE COPY!